Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin

Clinical trial NCT05730283 · RECRUITING

Trial details

NCT number: NCT05730283
Sponsor: Kevin Winthrop
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ototoxicity, Drug-Induced

Start date: 2025-06-02
Primary completion: 2028-02-29
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.